Pharmacology Flashcards

(38 cards)

1
Q

competitive inhibitors

A
  • resemble substrate
  • can be overcome by increasing substrate
  • binds active site
  • does not affect Vmax
  • increases Km
  • less potent
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

competitive inhibitors, irrersible

A
  • resembles substrate
  • cant be overcome by increasing substrate
  • binds active site
  • lowers Vmax
  • unchanged Km
  • less efficacious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

noncompetitive inhibitors

A
  • doesn’t resemble substrate
  • cant by overcome by increasing substrate
  • does not bind active site
  • lowers Vmax
  • does not affect Km
  • less efficacious
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

bioavailability (F)

A

fraction of drug that reaches the systemic circulation

- IV dose = 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

volume of distribution

A

volume occupied by total amount of drug in body relative to plasma concentration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Vd equation

A

Vd = amount of drug/concentration (mg/mg/ml=ml)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

low Vd

A

stays in IV space, large/charged molecules, protein bound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

high Vd

A

in all tissues, small lipophilic molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

clearance

A

volume of drug clear per unit time

- can change based on organ function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

clearance equation

A

Cl = rate of elimination / drug concentration (mg/min / mg/ml)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

half life equation

A

t1/2 = Vd*0.693/Cl

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

loading dose equation

A

Cp * Vd / F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

maintenance dose equation

A

Cp *CL * dose interval / F

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

additive drug interaction

A

A + B = sum of effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

permissive drug interactions

A

A is required for full B effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

synergistic drug interactions

A

A + B = greater than sum of parts

17
Q

tachyphylactic drug interactions

A

acute decrease in response after administation

18
Q

zero order elimination

A

eliminated independent of concentration (constant amount)

19
Q

zero order drugs

A

phenytoin, ethanol, aspirin

20
Q

first order elimination

A

eliminated dependent on concentration (constant fraction)

21
Q

weak acids in urine

A

deprotonated form is ionized
will dissociate and stay trapped in urine
- in case of overdose, add base to remove H+ and keep drug in urine

22
Q

weak bases in urine

A

protonated is ionized

- in case of overdose, add acid to increase protonated form

23
Q

phase I drug metabolism

A

reduction, oxidation, hydrolysis with P450, yield slightly polar, water soluble metabolites

24
Q

phase II drug metabolism

A

conjugation (methylation, glucuronidation, acetylation, sulfation), very polar inactive metabolites
- slow acetylators have increased side effects

25
efficacious drug
high Vmax, unrelated to potency
26
potent drug
lowest dose that still causes symptoms | - unrelated to efficacy
27
competitive antagonist curve
shift curve right, does not change efficacy, can be overcome
28
noncompetitive antagonist curve
lowers curve (efficacy), doesn't change potency
29
partial agonist
acts at the same site, lower efficacy, potency is independent
30
sweat glands
are part of sympathetic pathway but are innervated by cholinergic fibers
31
nicotinic receptors
ligand gated Na/K channels - Nn = autonomic - Nm = neuromuscular junction
32
muscarinic receptors
G protein coupled receptors | - use Ach
33
alpha 1 effects
increase vascular smooth muscle, pupillary dilator muscle contraction, intestinal and bladder contraction
34
Gq pathway
receptor binding, phospholipase C converts PIP2 to IP# and DAG, activated PKC and increasing calcium
35
Gs pathway
receptor binding, increase in adenylyl cyclase, increase cAMP, protein kinase A, increase in calcium and blocks myosin light chain
36
Gi pathway
receptor binding, decrease in adenylyl cyclase, decrease cAMP, protein kinase A, decrease in calcium and activates myosin light chain
37
tetrodotoxin
puffer fish toxin | - binds voltage gated sodium channels preventing depolarization
38
ciguatoxin
reef fish toxin | - opens sodium channels causing depolarization